Dortmund
![dortmund facility dortmund facility](/sites/default/files/us/2022-07/dortmund_microparts_content-image.jpg)
The site in Dortmund plays a key role in manufacturing the propellant-free inhaler RESPIMAT® as well as all other products within the RESPIMAT® portfolio. Every year, the Boehringer Ingelheim microParts GmbH produces up to 45 million inhalation devices at this site with its more than 600 employees.
![scientist with face mask in laboratory scientist with face mask in laboratory](/sites/default/files/us/2022-07/dortmund_microparts_respimat_content-image.jpg)
In 2004, Boehringer Ingelheim acquired the Dortmund-based company Steag microParts, which has been known as the Boehringer Ingelheim microParts GmbH ever since. Serial production of the RESPIMAT® had already started in 2002. As part of the global production network of Boehringer Ingelheim, the Dortmund site is responsible for the manufacture of the RESPIMAT® inhaler, which is then packaged with its cartridges in Ingelheim, Germany, and Sant Cugat, Spain.
![man in laboratory man in laboratory](/sites/default/files/us/2022-07/dortmund_microparts_technical-center_content-image.jpg)
With the advent of the RESPIMAT® re-usable in 2019, this product is also now available in an environmental-friendly reusable variant. Since 2020, the Dortmund site also manufactures the core elements for the Aservo® EquiHaler®, an inhalation therapy for horses, which is based on the RESPIMAT® technology.
Related Content
![boehringer ingelheim - ingelheim facility boehringer ingelheim - ingelheim facility](/sites/default/files/us/2022-07/headquarter_ingelheim_card_0.jpg)
Ingelheim
![biberach facility biberach facility](/sites/default/files/us/2022-07/59_PHARMACOLOGY_BIBERACH_0.jpg)
Biberach
![sant cugat facility sant cugat facility](/sites/default/files/us/2022-07/sant_cugat_content-image_0.jpg)